Ranbaxy Wins Case, Signs For Two Deals | Chemical & Engineering News
Volume 85 Issue 23 | p. 18 | Concentrates
Issue Date: June 4, 2007

Ranbaxy Wins Case, Signs For Two Deals

Department: Business

A court in Oslo, Norway, ruled last week that four of Pfizer's patents covering Lipitor are either invalid or not infringed by a proposed generic atorvastatin product made by India's Ranbaxy Laboratories. The ruling clears the way for Ranbaxy to market its generic version of the world's leading anticholesterol statin in Norway. Pfizer says it will appeal the ruling. Meanwhile, Ranbaxy has acquired U.S. rights to 13 dermatological drugs from Bristol-Myers Squibb. And the company has taken a 15% stake in Indian peptide drugmaker Jupiter Bioscience.

 
Chemical & Engineering News
ISSN 0009-2347
Copyright © American Chemical Society

Leave A Comment

*Required to comment